Search Results - "Kalofonos, HP"

Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? by Argyriou, Andreas A, Polychronopoulos, Panagiotis, Koutras, Angelos, Iconomou, Gregoris, Gourzis, Philippos, Assimakopoulos, Konstantinos, Kalofonos, Haralabos P, Chroni, Elisabeth

“…The current setting tested the hypothesis that advanced age would be strongly associated with increased incidence and severity of chemotherapy-induced…”
Get full text

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature by Argyriou, Andreas A, Kyritsis, Athanasios P, Makatsoris, Thomas, Kalofonos, Haralabos P

“…Commonly used chemotherapeutic agents in oncology/hematology practice, causing toxic peripheral neuropathy, include taxanes, platinum compounds, vinca…”
Get full text

Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination by Iconomou, G, Viha, A, Vagenakis, A G, Kalofonos, H P

“…[corrected] The aim of the study was to evaluate prospectively the analgesic efficacy, toxicity and acceptability of the transdermal fentanyl therapeutic…”
Get more information

Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study by Argyriou, Andreas A., Cavaletti, Guido, Antonacopoulou, Anna, Genazzani, Armando A., Briani, Chiara, Bruna, Jordi, Terrazzino, Salvatore, Velasco, Roser, Alberti, Paola, Campagnolo, Marta, Lonardi, Sara, Cortinovis, Diego, Cazzaniga, Marina, Santos, Cristina, Psaromyalou, Aikaterini, Angelopoulou, Aikaterini, Kalofonos, Haralabos P.

“…BACKGROUND The current prospective, multicenter study sought to identify single nucleotide polymorphisms of voltage‐gated sodium channels (SCNAs) genes that…”
Get full text

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients by Argyriou, A.A., Velasco, R., Briani, C., Cavaletti, G., Bruna, J., Alberti, P., Cacciavillani, M., Lonardi, S., Santos, C., Cortinovis, D., Cazzaniga, M., Kalofonos, H.P.

“…To report our prospective experience on the incidence and pattern of oxaliplatin (OXA)-induced peripheral neuropathy (OXA-IPN) in patients with colorectal…”
Get full text

The presence of Post-Traumatic Stress Disorder in cancer survivors and its impact on health-related quality of life: A cross-sectional study by Assimakopoulos, K., Iconomou, G., Karaivazoglou, K., Koutras, A., Georgila, E., Hyphantis, T., Kalofonos, H.P.

“…Aims: Cancer diagnosis constitutes a major stressor which challenges patients' physical, emotional and social resources. Several investigations have revealed…”
Get full text

Abstract P1-07-24: Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A hellenic cooperative oncology group (HeCOG) study by Koutras, A, Kotoula, V, Koliou, G-A, Kouvatseas, G, Christodoulou, C, Pectasides, D, Batistatou, A, Bobos, M, Tsolaki, E, Papadopoulou, K, Pentheroudakis, G, Papakostas, P, Pervana, S, Petraki, K, Chrisafi, S, Razis, E, Psyrri, A, Bafaloukos, D, Kalogeras, KT, Kalofonos, HP, Fountzilas, G

“…Background-aim: Metastatic breast cancer (MBC) is an incurable disease. Trastuzumab, a recombinant humanized monoclonal antibody, was found to significantly…”
Get full text

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial by ARGYRIOU, A. A, CHRONI, E, KOUTRAS, A, ELLUL, J, PAPAPETROPOULOS, S, KATSOULAS, G, ICONOMOU, G, KALOFONOS, H. P

“…The authors conducted a pilot, randomized, open label with blind assessment, controlled trial to determine whether vitamin E supplementation has a…”
Get full text

Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy by Iconomou, Gregoris, Mega, Vasiliki, Koutras, Angelos, Iconomou, Alexander V., Kalofonos, Haralabos P.

“…BACKGROUND The current study sought to delineate prospectively the rates and clinical course of emotional distress, cognitive impairment, and quality of life…”
Get full text

Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas by Skandalis, Spyros S, Labropoulou, Vassiliki T, Ravazoula, Panagiota, Likaki-Karatza, Eleni, Dobra, Katalin, Kalofonos, Haralabos P, Karamanos, Nikos K, Theocharis, Achilleas D

“…Mammographic density (MD) and malignant-appearing microcalcifications (MAMCs) represent the earliest mammographic findings of non-palpable breast carcinomas…”
Get full text

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group by Fountzilas, G., Skarlos, D., Dafni, U., Gogas, H., Briasoulis, E., Pectasides, D., Papadimitriou, C., Markopoulos, C., Polychronis, A., Kalofonos, H. P., Siafaka, V., Kosmidis, P., Timotheadou, E., Tsavdaridis, D., Bafaloukos, D., Papakostas, P., Razis, E., Makrantonakis, P., Aravantinos, G., Christodoulou, C., Dimopoulos, A.-M.

“…Purpose: The aim of this study was to explore the effect of dose-dense sequential chemotherapy with or without paclitaxel primarily on disease-free survival…”
Get full text

Advanced stage mucinous epithelial ovarian cancer: The Hellenic Cooperative Oncology Group experience by Pectasides, Dimitrios, Fountzilas, George, Aravantinos, Gerasimos, Kalofonos, Haralampos P., Efstathiou, Eleni, Salamalekis, Emmanouel, Farmakis, Dimitrios, Skarlos, Dimosthenis, Briasoulis, Evangelos, Economopoulos, Theofanis, Dimopoulos, Meletios A.

“…Mucinous epithelial ovarian cancer (mEOC) representing about 10% of all EOC are known to be possibly resistant to platinum-based chemotherapy and bear a poorer…”
Get full text

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma : A phase II study of the hellenic cooperative oncology group by BAMIAS, Aristotle, MOULOPOULOS, Lia A, KALOFONOS, Haralambos P, DIMOPOULOS, Meletios A, KOUTRAS, Aggelos, ARAVANTINOS, Gerassimos, FOUNTZILAS, George, PECTASIDES, Dimitris, KASTRITIS, Efstathios, GIKA, Dimitros, SKARLOS, Dimosthenis, LINARDOU, Helena

“…The toxicity of platinum-based combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported…”
Get full text

Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy by Binda, Davide, Cavaletti, Guido, Cornblath, David R., Merkies, Ingemar S. J.

“…Composite scales such as the Total Neuropathy Score clinical version (TNSc©) have been widely used to measure neurological impairment in a standardized manner…”
Get full text

Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy? by Antonacopoulou, A. G., Argyriou, A. A., Scopa, C. D., Kottorou, A., Kominea, A., Peroukides, S., Kalofonos, H. P.

“…Aim:  To assess the significance of the ITGB3 polymorphism at residue 33 (ITGB3 L33P) in the development of chronic oxaliplatin‐induced peripheral neuropathy…”
Get full text

Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer by Argyriou, Andreas A, Polychronopoulos, Panagiotis, Iconomou, Gregoris, Koutras, Angelos, Makatsoris, Thomas, Gerolymos, Miltiadis K, Gourzis, Philippos, Assimakopoulos, Konstantinos, Kalofonos, Haralabos P, Chroni, Elisabeth

“…The current prospective study sought to trace the incidence and severity of oxaliplatin-induced peripheral neuropathy (OXLIPN) and to determine its clinical…”
Get more information

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study by Kalofonos, H.P., Aravantinos, G., Kosmidis, P., Papakostas, P., Economopoulos, T., Dimopoulos, M., Skarlos, D., Bamias, A., Pectasides, D., Chalkidou, S., Karina, M., Koutras, A., Samantas, E., Bacoyiannis, C., Samelis, G.F., Basdanis, G., Kalfarentzos, F., Fountzilas, G.

“…Background:: Irinotecan (IRI) and oxaliplatin (OXA) are effective in the treatment of colorectal cancer. Previously untreated patients with advanced colorectal…”
Get full text

Lack of association of the M129V polymorphism of the PRNP gene with pseudoexfoliation syndrome by Giannakopoulos, Marios P, Antonacopoulou, Anna G, Kottorou, Anastasia E, Kalofonos, Haralabos P, Gartaganis, Sotirios P

“…In this study we aimed to evaluate the polymorphism at codon 129 (M129V) of the PRNP gene as a secondary risk factor for pseudoexfoliation syndrome (PEX). Two…”
Get full text

Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted? by Argyriou, Andreas A, Polychronopoulos, Panagiotis, Koutras, Angelos, Iconomou, Gregoris, Iconomou, Alexander, Kalofonos, Haralabos P, Chroni, Elisabeth

“…The goal of this study was to investigate the potential role of clinical and electrophysiological signs of chemotherapy-induced neurotoxicity (CIPN) in…”
Get full text

Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) by Skarlos, D.V., Samantas, E., Briassoulis, E., Panoussaki, E., Pavlidis, N., Kalofonos, H. P., Kardamakis, D., Tsiakopoulos, E., Kosmidis, P., Tsavdaridis, D., Tzitzikas, J., Tsekeris, P., Kouvatseas, G., Zamboglou, N., Fountzilas, G.

“…Summary Background Concurrent platinum-etoposide chemotherapy given in combination with hyperfractionated thoracic radiation therapy (HTRT) in limited disease…”
Get full text